- Report
- May 2024
- 134 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- May 2024
- 133 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- May 2024
- 133 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- May 2024
- 130 Pages
Global
From €6122EUR$6,499USD£5,235GBP
- Report
- June 2024
- 238 Pages
Global
From €7489EUR$7,950USD£6,404GBP
- Report
- July 2024
- 200 Pages
Global
From €4662EUR$4,949USD£3,986GBP
- Report
- September 2024
- 121 Pages
North America
From €5605EUR$5,950USD£4,793GBP
- Report
- August 2022
- 118 Pages
Global
From €4239EUR$4,500USD£3,625GBP
- Report
- April 2023
- 160 Pages
Global
From €4662EUR$4,949USD£3,986GBP
- Report
- January 2024
- 386 Pages
Global
€4705EUR$4,995USD£4,023GBP
- Report
- January 2024
- 113 Pages
United States
€3297EUR$3,500USD£2,819GBP
- Report
- April 2025
- 50 Pages
Global
From €2496EUR$2,650USD£2,135GBP
Tazarotene is a topical retinoid used in the treatment of acne, psoriasis, and other dermatological conditions. It is available in both gel and cream formulations, and is typically applied once daily. Tazarotene works by reducing inflammation and promoting the shedding of dead skin cells, which helps to reduce the appearance of acne and psoriasis. It also helps to reduce the production of sebum, which can lead to clogged pores and acne.
Tazarotene is a popular choice for treating acne and psoriasis due to its effectiveness and low risk of side effects. It is generally well-tolerated, although some people may experience skin irritation or dryness.
The tazarotene market is highly competitive, with a number of companies offering products. These include Galderma, Mylan, and Sun Pharmaceuticals. Other companies such as Allergan, GlaxoSmithKline, and Pfizer also offer tazarotene products. Show Less Read more